Keywords: update, genzyme, gets, go-ahead, fabrazyme, food, drug

Update: Genzyme gets US go-ahead for Fabrazyme

Article | 05 May 2003

The US Food and Drug Administration has granted marketing approval toGenzyme for its Fabrazyme (agalsidase beta) enzyme replacement therapy for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing

Related Drugs

Agalsidase Beta

Fabrazyme

Go to drug listing